MedTrace Logo

A Non-interventional Study to Observe the Computed Tomographic Angiography Image Quality With Different Contrast Media Injection Protocols Under Different Computed Tomography Machines Parameters Setting

NCT02840903 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1214

Last updated 2018-10-02

No results posted yet for this study

Summary

The objective of this study is to evaluate the image quality for different iodine delivery rates at different low voltage scanning protocols (80 or 100 kV ) under the modern advanced Multi-Detector Computed Tomography (MDCT) considering the body weight of patients.

Conditions

  • Angiography
  • Multidetector Computed Tomography

Interventions

DRUG

Iopromide (Ultravist, BAY86-4877)

8 settings for CT Angiography as described in group description.

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-26
Primary Completion
2017-07-28
Completion
2017-10-11

Countries

  • China

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02840903 on ClinicalTrials.gov